Audrey Sirvent

Montpellier, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

SLAP controls mTORC2 integrity via UBE3C-mediated non-degradative mLST8 ubiquitination to suppress colorectal tumorigenesis.

SLAP controls mTORC2 integrity via UBE3C-mediated non-degradative mLST8 ubiquitination to suppress colorectal tumorigenesis.

Journal: Cell death and differentiation

Published: March 07, 2025

Progastrin Promotes Colorectal Cancer Stem Cell-Like Properties via the Receptor PZR.

Progastrin Promotes Colorectal Cancer Stem Cell-Like Properties via the Receptor PZR.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 04, 2025

Lipid-driven Src self-association modulates its transformation capacity.

Lipid-driven Src self-association modulates its transformation capacity.

Journal: Life science alliance

Published: August 27, 2024

New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance.

New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance.

Journal: Frontiers in oncology

Published: May 30, 2022

Correction to: Regulation of Src tumor activity by its N-terminal intrinsically disordered region.

Correction to: Regulation of Src tumor activity by its N-terminal intrinsically disordered region.

Journal: Oncogene

Published: February 22, 2022

Regulation of Src tumor activity by its N-terminal intrinsically disordered region.

Regulation of Src tumor activity by its N-terminal intrinsically disordered region.

Journal: Oncogene

Published: April 22, 2021

Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis.

Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis.

Journal: Cancers

Published: June 17, 2020

Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer.

Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer.

Journal: Frontiers in oncology

Published: December 10, 2019

Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer.

Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer.

Journal: Cancers

Published: April 24, 2019

DDR1 inhibition as a new therapeutic strategy for colorectal cancer.

DDR1 inhibition as a new therapeutic strategy for colorectal cancer.

Journal: Molecular & cellular oncology

Published: April 11, 2018

Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.

Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.

Journal: EMBO molecular medicine

Published: February 14, 2018

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis.

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 26, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026